Mulmit

CYTOKINETICS INCCYTOKINETICS INC

CYTK Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3188,039,000-612,258,000-784,955,000-6.54
2024-12-3118,474,000-536,248,000-589,526,000-5.26
2023-12-317,530,000-496,205,000-526,244,000-5.45
2022-12-3194,588,000-324,202,000-388,955,000-4.33
2021-12-3170,428,000-186,313,000-215,314,000-2.8

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-01PARSHALL B LYNNE5,000
2026-08-31Callos AndrewEVP, Chief Commercial Officer10,000
2026-08-31Callos AndrewEVP, Chief Commercial Officer10,000
2026-08-31Callos AndrewEVP, Chief Commercial Officer10,000
2026-08-31Blum Robert IPresident & CEO7,500
2026-08-31Blum Robert IPresident & CEO7,500
2026-08-31Blum Robert IPresident & CEO7,500
2026-08-18Malik Fady IbrahamEVP Research & Development3,500
2026-08-18Malik Fady IbrahamEVP Research & Development3,500
2026-08-18Malik Fady IbrahamEVP Research & Development3,500
2026-08-10Blum Robert IPresident & CEO7,500
2026-08-10Blum Robert IPresident & CEO7,500

8-K events

FiledItems
2026-08-28Other events · Financial statements and exhibits
2026-08-13Other events
2026-08-06Results of operations · Financial statements and exhibits
2026-05-27Submission of matters to a vote
2026-05-08Other events · Financial statements and exhibits
2026-05-05Other events · Financial statements and exhibits
2026-05-05Results of operations · Financial statements and exhibits
2026-02-24Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.